Lonza | LONN - Equity Capital And Reserves

Stock Price
481.35
Daily Change
-7.25 -1.48%
Monthly
-3.42%
Yearly
-17.97%
Q2 Forecast
470.40

Lonza reported CHF9.13B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Akzo Nobel EUR 4.88B 222M Mar/2026
Alcon AG USD 22.03B 52M Dec/2025
Almirall EUR 1.49B 24.03M Dec/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
BASF EUR 33.2B 434M Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
Beiersdorf EUR 8.6B 133M Dec/2025
Covestro EUR 7B 908M Dec/2025
Demant DKK 9.84B 446M Dec/2025
Fresenius EUR 18.62B 320M Sep/2025
Fresenius Medical Care EUR 249.82M 12.7B Dec/2025
Geberit CHF 1.54B 237.4M Mar/2025
Genmab DKK 5.85B 96M Dec/2025
Givaudan CHF 4.54B 430M Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
GN Store Nord DKK 14.88B 4.33B Dec/2025
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Johnson Matthey GBP 2.1B 194M Dec/2025
Merck EUR 28.59B 344M Dec/2025
Novartis USD 46.13B 1.38B Dec/2025
Philips EUR 10.58B 204M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 72.81B 1.1B Mar/2026
Sika AG CHF 6.66B 481.4M Dec/2025
Smith & Nephew USD 5.54B 331M Dec/2025
Solvay EUR 1.02B 245M Dec/2025
UCB EUR 10.87B 1.18B Dec/2025